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1. SUMMARY 
We analyzed an Escherichia coli strain which 
harbours a chromosomal mutation that blocks the 
hemolysin excretion. Compartmentation studies 
showed that hemolysin accumulates in the cyto-
plasm and not in the periplasm. The mutation did 
not affect the SDS-PAGE protein pattern of the 
outer membrane, although some alterations were 
apparent in the periplasmic protein pattern. The 
mutant strain, E. coli Hsb-1 also failed to export a 
cloned fimbrial adhesin. The mutation maps in the 
min. 3.5 of the E. coli genetic map. 
2. INTRODUCTION 
In the last few years, the Escherichia coli 
alpha-hemolysin displayed by some uropathogenic 
strains [1-3], has been investigated mainly be-
cause of its role as a virulence factor. In addition, 
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this toxin seems to be one of the very few proteins 
which are truly excreted to the external medium 
by E. coli cells [4J. Attention has therefore been 
focused on the mechanism controlling hemolysin 
excretion. This process shows some unique fea-
tures: it has been reported that the cleavage of a 
N-terminal signal peptide is ,not required [5], and 
recent results have also shown that a C-terminal 
sequence of hemolysin is essential for the correct 
translocation of the toxin across the cell envelopes 
[6,7]. Nevertheless, the molecular mechanism of 
hemolysin excretion remains to be elucidated. The 
genetic determinant that allows E. coli to syn-
thesize and export hemolysin may be either of 
chromosomal or plasmid origin. Irrespective of 
this, it includes two genes, hlyB and hlyD, which 
are specifically required for the correct export of 
the active toxin to the external medium [1,8]. To 
date, the role of their gene products is poorly 
understood. Besides both the HlyB and HlyD 
proteins, i t has been shown that other chro-
mosomally coded functions also play a role in 
hemolysin export. We have already reported the 
isolation of a chromosomal mutation that blocked 
hemolysin secretion in E. coli. This mutation ap-
peared to be specific for hemolysin export and did 
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not affect the secretion to the periplasm of the 
ß-lactamase, or the release of colicins to the exter-
nal medium [9]. Here we further characterize such 
a mutant, and test the effect of the mutation on 
the export of a fimbrial agglutinin which is consid-
ered a protein translocated by E. coli to the exter-
nal surface. 
3. MATERIALSAND METHODS 
3.1. Bacterial strains, plasmzds and media 
The bacterial strains and plasmids used are 
listed in Table 1. LB medium [10] was routinely 
used for the maintenance and growth of the strains 
used. When required, ampicillin, chloramphenicol 
and tetracycline were prepared and used for sup-
plementing the culture media at the concentra-
tions indicated by Maniatis et al. [11 ]. 
3.2. Genetic techniques 
Plasmid transformation and ·DNA isolation 
were performedas previously described [12]. Gen-
eralized transduction with Plcm clr 100 phage was 
done as described by Miller [10]. For mapping 
experiments, an Hfr collection containing inser-
tians of Tn 10 around the E. coli chromosome was 
used [13] (Table 2). Fine mapping was performed 
by transducing Tn 10 insertions near the region 
where the mutations were localized. 
Table 1 
Bacterial strains and plasmids 
Strain or plasmid Relevant phenotype 
F-, r; m;, rpsL, thr, th1~ Ieu. lacZ 
Table 2 
Hfr-Tn 10 mapping strains (B. Bachmann) 
Strain Hfr point Position of 
of origin the TnlO 
insertion 
BW7261 P021 /eu63 
BW7623 P043 purE 
BW7622 P044 trpBJJ4 
BW6160 P0118 zdh-57 
BW6163 P045 zed-977 
BW5660 P066 sr/c-300 
BW6169 P013 argA 
BW6166 P018 zhf-721 
BW6159 P068 i/v-691 
BW6175 P0131 argE 
BW6156 P03 zje 
BW6164 P048 thr-43 
3. 3. H emolysin assay 
The hemolytic activity was measured as fol-
lows. Bovine erythrocytes (6 ml) were washed 
several times with 0.9% NaCI and resuspended in 
130 ml of the same solution, to which 20 ml of 0.2 
M CaC1 2 were added. 600 ~-tl of this solution were 
mixed with 10-100 J.tl of the corresponding sam-
ple to be assayed, and incubated at 37 ° C. At 
different times, the samples were centrifuged (Ep-
pendorf centrifuge) for 30 s and the release of 
hemoglobin wasmonitoredas the increase in OD 
at 543 nm. In order to compare the hemolytic 
activity in the supernatants of different cultures, 
Source or reference 
[12] 5K 
HBlOl F-, hsd S20 (rß mji ), supE 44, ara-14, ga/K-2, lacYI, proA2, 
Hsb-1 
536 
NK5525 
JP3123 
NK5148 
NK6034 
SJ2 
X2844 
pANN202-312 
pANN202-312R 
pANN801-l 
rpsL20, xy/-5, mt/-1, X-, recA 13 
5K hsb-1:: Mudl 
06:K15:H31 
F-, pro-8/::TnJO, X-
F-, /acY, aroL::TnlO, purE, tyrR. rpsL, xyl, mtl 
F-, thr-34::Tnl0, X-
Hfr (POl), car-96::Tnl0, relA, il(gpt-lac)5, spoT, thi, X-
Hfr (POl), panB, zad-220::Tnl0, re/A, spoT, thi, X-
F-, tsx-462::Tn10, X-
hlyC +, hlyA +, hlyB +, hlyD +, Cmr 
hlyR +, hlyC +, hlyA +, hlyB +, hlyD +, Cmr 
mrh+, Tcr 
[16] 
[9] 
[16] 
B. Bachmann 
B. Bachmann 
B. Bachmann 
B. Bachmann 
B. Bachmann 
[12] 
[7] 
[16] 
the following units were used: 1 hemolytic unit = 
OD543/0D600 X min X ml. For the periplasmic and 
cytoplasmic fractions, the hemolytic activity was 
calculated as specific activity (unitsjmg protein). 
3. 4. Ce// fractionation 
Cell fractionation was performed as described 
previously [14]. Proteins were separated on 10-13% 
polyacrylamide gels [151 in a minigel apparatus 
(Bio-Rad Laboratories, Richmond, CA, U.S.A.). 
. 3.5. Agglutination 
Cells were grown in LB until an 00600 of 0.8 
was reached. Remagglutination was tested in mi-
crotiter plates using bovine erythrocytes as previ-
ously described [16]. 
4. RESULTS 
4.1. Compartmentation of hemolysin in strain Hsb-1 
To determine at which stage of the secretion 
process the mutant Hsb-1 is blocked, we studied 
the compartmentation of hemolysin in both this 
mutant and the parental 5K · strain. As hemolytic 
determinants we used either the plasmid 
pANN202-312, which was initially used for the 
isolation of the Hsb mutant [9], or its derivative 
pANN202-312R. When strain 5K harbours the 
latter plasmid, the hemolytic activity is signifi-
cantly increased in all cellular compartments, 
especially in the extemal medium (Table 3). When 
transformed with pANN202-312, strain Hsb-1 
failed to excrete hemolysin, and hemolytic activity 
was present only in the cytoplasmic compartment 
Table 3 
Hemolysin production of strains SK and Hsb-1 
Strain Hemolytic activity 
Exter- Periplas- Cytoplas-
naJ a mic b mic b 
5K(pANN202-312) 
Hsb-l(pANN202-312) 
5K{pANN202-312R) 
Hsb-1(pANN202-312R) 
a Values are given as units. 
0.005 
< 0.001 
5.05 
0.21 
h Values are given as specific activity. 
0.36 
< 0.001 
0.93 
0.04 
0.25 
0.17 
0.91 
0.38 
94-
67-
43-
30-
20-
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Fig. 1. SOS-PAGE periplasmic protein patterns from strains 
SK and Hsb-1. A: 5K; B: 5K(pANN202-312); C: 
5K(pANN202-312R); D: Hsb-l(pANN202-312); E: Hsb-1; F: 
Hsb-l(pANN202-312R). 
(Table 3). In contrast, Hsb-1 clones harbouring 
pANN202-312R showed external as well as peri-
plasmic hemolytic activity. Nevertheless, the activ-
ity values obtained for both fractions were no 
more than 5-10 % of those obtained for strain 5K 
(pANN202-312R) (Table 3). 
4.2. Analysis of ce/1 envelopes from strain Hsb-1 
To obtain information about the effect of the 
hsb mutation on the cel1 envelopes of strain Hsb-1, 
the protein composition of the outer membrane 
and periplasmic fractions was analyzed by SOS-
PAGE. The outer membrane protein pattern was 
found to be identical to that of the parental strain 
5K ( data not shown). In contrast, different alter-
ations were observed when the electrophoretic 
profiles of the periplasmic content were compared 
(Fig. 1). Some of them affected the relative ratios 
of different periplasmic proteins. Additionally, a 
major alteration was the absence of one 50 kDa 
protein in strain Hsb-1. Interestingly, this protein 
was found to be absent only when strain Hsb·1 
harboured either pANN202-312 or its derivative 
pANN202-312R (Fig. 1), and appeared in the 
periplasmic content of the plasmid free mutant 
strain. 
4.3. Expression of a fimbrial adhesin in strain Hsb-1 
Previous results have shown that the hsb muta-
tion did not affect either the secretion of the 
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Table 4 
Agglutination of E. co/i Hsb-1 carrying plasmid pANN801-l 
Strain Plasmid Agglutination 
title 
HB101 pANN801-1 a 1:16 
5K pANN801-1 a 1:16 
Hsb-1 pANN801-l a <1:1 
HB101 pANN801-1 b 1:16 
HB101 None <1:1 
536 None 1:2/0 
a Plasrnid DNA obtained from strain HB101. 
b Plasrnid DNA reisolated from strain Hsb-1. 
ß-lactamase to the periplasm, or the release of 
colicins to the extemal medium [9]. Secretion of 
ß-lactamase represents a translocation thtough the 
inner membrane, and the release of colicins seems 
to be caused by a specific mechanism, different 
from other secretion models and to hemolysin 
secretion itself [17,18]. In addition to this toxin, 
the fimbrial subunits and adhesins arealso consid-
ered proteins which E. coli translocates to the 
external surface. Although no connection has been 
established until now between the two export 
mechanisms, we were interested to see if the hsb 
mutation could affect the adhesin transport. Strain 
Hsb-1 was transformed with the recombinant 
plasmid pANN801-1 (Mrh + Firn-), which codes 
for the agglutinin determinant of E. coli 536, and 
the agglutinating activity of the tetracycline re-
sistant transformants was tested. It was not possi-
ble to detect any agglutination for strain Hsb-1 
(Table 4). The inability to agglutinate was not due 
Table 5 
Frequency of coinheritance of tetracycline resistance and ex-
tracelJular hemolysin production in the matings of the Hfr-Tn 10 
strains with Hsb-1 mutant 
Donor strain TnlO map Frequency of 
position coinheri tance 
(min) Tcr Hty+ 
BW6159 85 0.06 
BW6175 90 0.31 
BW6156 94 0.50 
BW6164 100 0.60 
BW7261 2 0.75 
BW7623 12 0.33 
Table 6 
Cotransduction frequency between tetracycline resistance and 
extracelJular hemolysis production 
PI Iysate obtained TnJO map Frequency 
from strain position (rnin) of Tcr Hly+ 
transductants 
NK5148 0 0 
NK6034 0 
SJ2 3.5 0.91 
NK5525 6 0 
JP3123 9 0 
2844 9 0 
to changes in the recombinant plasmid pANN801-
1 because. after reisolation of this plasmid from 
strain Hsb-1, it retained the coding capacity for 
hemagglutination when retransformed in E. coli 
HB101 (Table 4). 
4.4. Mapping of the hsb mutation 
The location of the mutation in the E. coli 
chromosome was ini tially determined by using a 
Hfr::TnJO kit [13]. As the mutant was obtained 
by Mudl insertion, both Hfr matings and Pl 
transductions are easier to carry out with the 
TnlO transposon than with the much !arger Mudl 
genome. After crossing the different Hfr strains 
with strain Hsb-1 (pANN202-312), Tcr Smr clones 
were selected and tested for external hemolysin 
production. Hemolytic transconjugants ~ould o~ly 
be isolated using as donors Hfr strams which 
contained TnlO inserted between mins. 85 and 12 
of the E. coli genetic map, showing the highest 
frequency strains with Tn 10 inserts between mins. 
0 and 12 (Table 5). For fine mapping, TnlO 
inserts covering this latter region were Pl-trans-
duced to strain Hsb-1, selecting for Te trans-
ductants with hemolysis halos. Such a phenotype 
could be only obtained with P1 lysates grown on 
strain E. coli SJ2 (zad-220: :Tn 10). The Tcr phe-
notype in this strain is 96-98% cotransducible 
with panD. The cotransduction frequency that we 
obtained for Tcr and Hlye:t was 91% (Table 6). 
Thus, we located the Mu dl insert to about min. 
3.5 of the E. coli genetic map, close to panD. 
5. DISCUSSION 
The results presented above suggest that the 
stage at wbich hemolysin export is blocked in 
strain Hsb-1 is the translocation of the toxin 
through the inner membrane. W e failed to detect 
hemolytic activity in the periplasmic compartment 
of strain Hsb-1, harbouring the multicopy hemo-
lytic plasmid pANN202-312. Although this strain 
shows extemal as weil as periplasmic hemolytic 
activity when it carries pANN202-312R, the activ-
ity values are much lower than those obtained for 
the parental strain. These results show that the hsb 
mutation does not completely block hemolysin 
excretion. The increase in cytoplasmic hemolysin 
concentration caused by pANN202-312R allows a 
small percentage of hemolysin to be exported to 
the extemal medium, and Hsb clones harbouring 
this plasmid show small hemolysis halos on blood 
agar plates. In fact, we have been unable to isolate 
non-hemolytic mutants of 5K (pANN202-312R) 
(A. Juärez, unpublished data). 
Supporting the results indicating that hemo-
lysin accumulates in the cytoplasm of strain Hsb-1 
and not in the periplasm, we show that when 
strain Hsb-1 harboured either pANN202-312 or 
pANN202-312R, SDS-PAGE analysis of the peri-
plasmic proteins failed to show the 110 kDa poly-
peptide which corresponds to the hemolysin. It 
has been shown that HlyB and HlyD proteins 
appear to be associated primarily with the cyto-
plasmic membrane [1]. Based on these results, it 
has been proposed that both HlyB and HlyD may 
form a transenvelope channel, thus allowing the 
exit of hemolysin [19]. Assuming this hypothesis, 
the hsb gene(s) product(s) may be essential either 
for the correct assembly of the channel structure 
in the inner membrane, or for the interaction 
between hemolysin and HlyB and HlyD proteins. 
The fact that, when harbouring either pANN202-
312 or pANN202-312R, strain Hsb-1 Iacks at least 
one major periplasmic protein, suggests that a 
defective translocation of hemolysin through the 
inner membrane interferes with the secretion of 
other periplasmic components. 
A remarkable finding is that strain Hsb-1 also 
fails to agglutinate when harbouring a recombi-
nant plasmid, which contains the agglutinin de-
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terminant. The results we present here suggest that 
both hemolysins and agglutinins may share some 
common cellular secretion factors, one of them 
being defective in strain Hsb-1. The map location 
of the hsb locus does not correlate it to other 
previously known genes affecting protein export 
in E. coli. Cloning of the hsb sequences and 
identification of the gene products coded may 
help to better understand the mechanism by which 
E. coli hemolysin is excreted to the external 
medium. 
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